F A Macneill

Suggest Changes
Learn More
The extent of primary surgery for breast cancer could be tailored to the patient if previous information on the presence or absence of lymph node involvement could be reliably determined. Prospective(More)
Criscitiello et al. [1], reporting on the NeoAdjuvant Lapatinib and/or Trastuzumab Treatment Optimization (NeoALTTO) trial, elegantly analyse multiple factors which might account for why high(More)